1. A method for cleaning a rotating surface of a printing press cylinder or a rotating surface of a printing press roller, or a rotating surface of a print form or a transfer form arranged on a printing press cylinder within a printing unit, the method comprising the steps of:
applying a liquid, water-based washing agent comprising at least 60% water and the rest at least surfactants, onto the surface;
dissolving contaminations from the surface with the washing agent and a cleaning device; and
removing the dissolved contaminations from the surface at least with the cleaning device.
2. The method according to claim 1, wherein the washing agent comprises at least 80% water and the rest at least surfactants.
3. The method according to claim 2, wherein the washing agent comprises at least 80% water, between 10% and 19% surfactants and between 1% and 10% of a solvent.
4. The method according to claim 1, wherein the surfactants of the washing agent comprises non-ionic surfactants and anionic surfactants.
5. The method according to claim 1, wherein the water-based washing agent is applied with the cleaning device in contact with the surface to be cleaned and rolling on the surface to be cleaned.
6. The method according to claim 5, wherein the washing agent is sprayed onto the cleaning device and is applied onto the surface to be cleaned with the cleaning device being a cleaning brush.
7. The method according to claim 1, wherein the cleaning device at least during the dissolving of the contaminations is pressed against the surface to be cleaned with a line pressure force such that the surface of a transfer form is elastically deformed between about 0.01 mm and about 0.20 mm.
8. The method according to claim 7, wherein the cleaning device presses against the surface to be cleaned of the transfer form with a line pressure force between about 0.5 Nmm and about 10 Nmm.
9. The method according to claim 1, wherein prior to applying the washing agent on the surface to be cleaned, the washing agent is heated to a temperature between about 30\xb0 C. and about 90\xb0 C.
10. The method according to claim 9, wherein the washing agent is heated to a temperature between about 40\xb0 C. and about 80\xb0 C.
11. The method according to claim 10, wherein the washing agent is heated to a temperature between about 50\xb0 C. and about 70\xb0 C.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A method to detect cancer in a subject, wherein the cancer is selected from liver cancer, lung cancer, breast cancer and glioma, comprising:
applying to a cell or tissue sample obtained from a subject an anti-DKK-1 specific antibody or a DKK-1 protein specific nucleic acid probe, wherein the anti-DKK-1 specific antibody binds to DKK-1 protein, wherein the DKK-1 protein specific nucleic acid probe binds to a nucleic acid sequence that encodes the DKK-1 protein, and wherein each of the DKK-1 protein and the nucleic acid sequence that encodes the DKK-1 protein is a molecular marker for the cancer;
measuring an amount of the DKK-1 protein or the nucleic acid sequence that encodes the DKK-1 protein by measuring an amount of a first signal generated by a first labeling substance that is conjugated to the anti-DKK-1 specific antibody or an amount of a second signal generated by a second labeling substance that is conjugated to the DKK-1 protein specific nucleic acid probe; and
comparing the amount of the DKK-1 protein or the nucleic acid sequence that encodes the DKK-1 protein in the cell or tissue sample with an amount of the DKK-1 protein or the nucleic acid sequence that encodes the DKK-1 protein in a normal control, wherein an increase in the amount of the DKK-1 protein or the nucleic acid sequence that encodes the DKK-1 protein in the cell or tissue sample as compared to the amount of the DKK-1 protein or the nucleic acid sequence that encodes the DKK-1 protein in the normal control indicates that the subject has the cancer.
2. The method of claim 1, wherein the anti-DKK-1 specific antibody is linked to a radionuclide.
3. The method of claim 1, wherein the anti-DKK-1 specific antibody is a monoclonal antibody or a polyclonal antibody.
4. The method of claim 1, wherein the cancer is liver cancer.
5. The method according to claim 1, wherein the subject is human.
6. The method according to claim 2, wherein the radionuclide is 133I.